Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,127,555
-$13,120,124 QoQ
Shares Held
130,184
-18.3% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#91
of 1,031 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. BIIB ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
427,913 | $513,251,732 | |
| 2 | JNJ |
Johnson & Johnson
|
1,477,212 | $375,167,531 | |
| 3 | NVS |
Novartis AG
|
1,002,335 | $157,085,941 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
929,682 | $117,456,023 | |
| 5 | ABBV |
AbbVie Inc.
|
180,108 | $45,322,377 | |
| 6 | BIIB |
Biogen Inc.
This page
|
130,184 | $28,127,555 | |
| 7 | AZN |
Astrazeneca PLC
|
64,127 | $12,159,761 |
All Filings in BIIB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,127,555 | 130,184 | Shares | Sole | 2026-08-14 | |
| 2023-12-31 | $41,247,679 | 159,399 | Shares | Sole | 2024-10-07 | |
| 2023-09-30 | $41,472,418 | 161,365 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $38,610,562 | 135,547 | Shares | Sole | 2024-10-07 | |
| 2022-12-31 | $73,194,109 | 264,315 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $3,853,077 | 14,431 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $65,002,496 | 187,722 | Shares | Other | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||